4.8 Article

Identification and validation of neurotrophic factor-related gene signatures in glioblastoma and Parkinson's disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemical Research Methods

Comprehensive Characterization of RNA-Binding Proteins in Colon Adenocarcinoma Identifies a Novel Prognostic Signature for Predicting Clinical Outcomes and Immunotherapy Responses Based on Machine Learning

Ye Miao et al.

Summary: A multi-gene signature was developed based on the expression profile of RNA-binding proteins (RBPs) to predict prognosis and immunotherapy response in patients with colon adenocarcinoma (COAD). The signature consisted of 8 genes and was able to categorize patients into high- and low-risk populations with different outcomes. The signature outperformed five other prediction models and a nomogram was generated for quantifying overall survival (OS) rate. Additionally, the study found that high-risk populations had enhanced immune evasion capacity, while low-risk populations might benefit from immunotherapy, particularly the combination of PD-1 and CTLA4 inhibitors.

COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2023)

Article Biochemistry & Molecular Biology

EN1 Regulates Cell Growth and Proliferation in Human Glioma Cells via Hedgehog Signaling

Jinchun Chang et al.

Summary: The study found that EN1 is highly expressed in glioma cells and tissues, and its increased expression level is associated with poor prognosis. EN1 influences glioma cell proliferation, migration, and sensitivity to radiation by regulating Gli1 levels and the primary cilia-related protein TULP3. These findings suggest that EN1 plays an oncogenic role in glioblastoma pathogenesis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Health Care Sciences & Services

Identification and Validation of a Gene Signature for Lower-Grade Gliomas Based on Pyroptosis-Related Genes to Predict Survival and Response to Immune Checkpoint Inhibitors

Guichuan Lai et al.

Summary: Pyroptosis-related gene signature has a significant impact on the prognosis and efficacy of immune checkpoint inhibitors (ICIs) in lower-grade gliomas (LGGs). High-risk patients have worse survival outcomes and distinct differences in tumor immune microenvironment, mutation status, and response to therapy compared to low-risk patients. These findings are valuable in predicting prognosis and guiding ICIs treatment for LGG patients.

JOURNAL OF HEALTHCARE ENGINEERING (2022)

Article Neurosciences

A Novel Classification Model for Lower-Grade Glioma Patients Based on Pyroptosis-Related Genes

Yusheng Shen et al.

Summary: This study identified two pyroptosis phenotypes in lower-grade glioma, which exhibited differences in cell infiltration characteristics and clinical characteristics. The PyroScore model was constructed to measure the level of pyroptosis in each patient, allowing for stratified prognosis and personalized management.

BRAIN SCIENCES (2022)

Article Genetics & Heredity

Identifying the role of transient receptor potential channels (TRPs) in kidney renal clear cell carcinoma and their potential therapeutic significances using genomic and transcriptome analyses

Jie Ren et al.

Summary: This study investigated the role of TRPs in KIRC and identified a prognostic signature with superior survival prediction. The study also found differences in immune checkpoint gene expression, tumor mutation burden, and immune subtypes and response between low-risk and high-risk subgroups, and identified potential drugs for different risk populations.

BMC MEDICAL GENOMICS (2022)

Article Endocrinology & Metabolism

Identification and validation of a prognostic risk-scoring model based on sphingolipid metabolism-associated cluster in colon adenocarcinoma

Qihang Yuan et al.

Summary: This study investigated the effects of sphingolipid metabolism-related genes on human cancers, specifically colon adenocarcinoma (COAD). Through analysis of gene data, the study found that sphingolipid metabolism is closely associated with the development and prognosis of COAD. A prognostic model based on sphingolipid metabolism was developed to quantitatively evaluate clinical outcomes.

FRONTIERS IN ENDOCRINOLOGY (2022)

Article Genetics & Heredity

A Novel 3-Gene Signature for Identifying COVID-19 Patients Based on Bioinformatics and Machine Learning

Guichuan Lai et al.

Summary: A novel gene signature comprising three genes (CLEC4D, DUSP13, and UNC5A) was developed to accurately distinguish COVID-19 patients. These genes may serve as potential biomarkers for COVID-19 patients.
Article Immunology

Comprehensive characterization of extracellular matrix-related genes in PAAD identified a novel prognostic panel related to clinical outcomes and immune microenvironment: A silico analysis with in vivo and vitro validation

Xu Chen et al.

Summary: The functions of ECM-related genes (ECMGs) in pancreatic adenocarcinoma (PAAD) were systematically evaluated. Seven ECMGs were identified as differentially up-regulated in PAAD and significantly linked to tumor stage and prognosis. A novel mRNA-lncRNA-based prognostic panel (ECM-APP) was developed and validated for accurately predicting clinical outcomes of PAAD patients.

FRONTIERS IN IMMUNOLOGY (2022)

Article Neurosciences

Glial cell line-derived neurotrophic factor increases matrix metallopeptidase 9 and 14 expression in microglia and promotes microglia-mediated glioma progression

Yimin Huang et al.

Summary: GDNF released by glioma cells promotes tumor growth by increasing MMP9 and MMP14 expression in microglial cells, mediated by specific receptors and signaling pathways. Additionally, GDNF enhances TLR1 and TLR2 expression, contributing to the pro-tumorigenic phenotype of microglia.

JOURNAL OF NEUROSCIENCE RESEARCH (2021)

Editorial Material Clinical Neurology

Cancer and Parkinson's Disease: Common Targets, Emerging Hopes

PanagiotaS. Filippou et al.

Summary: Cancer and neurodegeneration, seemingly distinct at first, actually show unexpected overlap in their underlying pathophysiological mechanisms. While most studies suggest an inverse association between neurodegenerative diseases and cancer, evidence points to a positive correlation between specific types of cancer and neurodegenerative diseases. Deciphering the molecular processes of one disease may significantly increase understanding of the other.

MOVEMENT DISORDERS (2021)

Article Oncology

hTERT Transduction Extends the Lifespan of Primary Pediatric Low-Grade Glioma Cells While Preserving the Biological Response to NGF

Ornella Franzese et al.

Summary: The study shows that transduction with hTERT can extend the proliferative potential of low-grade glioma (LGG) cells in vitro while maintaining biological responses to nerve growth factor (NGF). This provides a valid approach to increase the in vitro lifespan of patient-derived astrocytoma primary cultures.

PATHOLOGY & ONCOLOGY RESEARCH (2021)

Article Biochemistry & Molecular Biology

LOXL1 confers antiapoptosis and promotes gliomagenesis through stabilizing BAG2

Hua Yu et al.

CELL DEATH AND DIFFERENTIATION (2020)

Review Neurosciences

Immunotherapy for Parkinson's disease

Aaron D. Schwab et al.

NEUROBIOLOGY OF DISEASE (2020)

Review Oncology

PD-1 Inhibitors: Do they have a Future in the Treatment of Glioblastoma?

Mustafa Khasraw et al.

CLINICAL CANCER RESEARCH (2020)

Review Clinical Neurology

Bidirectional Relation Between Parkinson's Disease and Glioblastoma Multiforme

Pauline Mencke et al.

FRONTIERS IN NEUROLOGY (2020)

Review Clinical Neurology

Is Brain-Derived Neurotrophic Factor: A Common Link Between Neurodegenerative Disorders and Cancer?

Radhika Khosla et al.

CURRENT ALZHEIMER RESEARCH (2019)

Letter Oncology

Statistical predictions with glmnet

Solveig Engebretsen et al.

CLINICAL EPIGENETICS (2019)

Review Medicine, Research & Experimental

Innate Immunity and Neurodegeneration

Larisa I. Labzin et al.

ANNUAL REVIEW OF MEDICINE, VOL 69 (2018)

Article Biochemical Research Methods

GSCALite: a web server for gene set cancer analysis

Chun-Jie Liu et al.

BIOINFORMATICS (2018)

Review Neurosciences

Nerve Growth Factor: Early Studies and Recent Clinical Trials

Maria Luisa Rocco et al.

CURRENT NEUROPHARMACOLOGY (2018)

Review Neurosciences

Microglia in neurodegeneration

Suzanne Hickman et al.

NATURE NEUROSCIENCE (2018)

Article Biochemistry & Molecular Biology

AKT/GSK3β Signaling in Glioblastoma

Ewelina Majewska et al.

NEUROCHEMICAL RESEARCH (2017)

Review Neurosciences

Interactions between the microbiota, immune and nervous systems in health and disease

Thomas C. Fung et al.

NATURE NEUROSCIENCE (2017)

Review Oncology

BDNF: An Oncogene or Tumor Suppressor?

Daniel P. Radin et al.

ANTICANCER RESEARCH (2017)

Review Biochemistry & Molecular Biology

Neurotrophin signaling in cancer stem cells

Valerie Chopin et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2016)

Article Neurosciences

Direct α-synuclein promoter transactivation by the tumor suppressor p53

Eric Duplan et al.

MOLECULAR NEURODEGENERATION (2016)

Article Oncology

Glioblastoma: Overview of Disease and Treatment

Mary Elizabeth Davis

CLINICAL JOURNAL OF ONCOLOGY NURSING (2016)

Review Oncology

Nerve-Cancer Cell Cross-talk: A Novel Promoter of Tumor Progression

Phillip Jobling et al.

CANCER RESEARCH (2015)

Article Medicine, General & Internal

Parkinson's disease

Lorraine V. Kalia et al.

LANCET (2015)

Article Biochemical Research Methods

Robust enumeration of cell subsets from tissue expression profiles

Aaron M. Newman et al.

NATURE METHODS (2015)

Article Biochemistry & Molecular Biology

limma powers differential expression analyses for RNA-sequencing and microarray studies

Matthew E. Ritchie et al.

NUCLEIC ACIDS RESEARCH (2015)

Article Multidisciplinary Sciences

LOX Expression and Functional Analysis in Astrocytomas and Impact of IDH1 Mutation

Roseli da Silva et al.

PLOS ONE (2015)

Article Chemistry, Multidisciplinary

Molecular inversion probe-based SPR biosensing for specific, label-free and real-time detection of regional DNA methylation

Laura G. Carrascosa et al.

CHEMICAL COMMUNICATIONS (2014)

Article Medicine, General & Internal

A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

Mark R. Gilbert et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Review Biochemistry & Molecular Biology

The hallmarks of Parkinson's disease

Paul M. A. Antony et al.

FEBS JOURNAL (2013)

Article Biochemical Research Methods

The sva package for removing batch effects and other unwanted variation in high-throughput experiments

Jeffrey T. Leek et al.

BIOINFORMATICS (2012)

Article Biochemistry & Molecular Biology

Pten ablation in adult dopaminergic neurons is neuroprotective in Parkinson's disease models

Andrii Domanskyi et al.

FASEB JOURNAL (2011)

Review Neurosciences

Activated Immune Cells in Parkinson's Disease

Jun-Jun Cao et al.

JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2011)

Review Biotechnology & Applied Microbiology

Potential therapeutic uses of BDNF in neurological and psychiatric disorders

Alan H. Nagahara et al.

NATURE REVIEWS DRUG DISCOVERY (2011)

Article Geriatrics & Gerontology

Association of transcription factor polymorphisms PITX3 and EN1 with Parkinson's disease

Dietrich Haubenberger et al.

NEUROBIOLOGY OF AGING (2011)

Article Multidisciplinary Sciences

CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease

Antonella Caccamo et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Review Genetics & Heredity

Cancer and Neurodegeneration: Between the Devil and the Deep Blue Sea

Helene Plun-Favreau et al.

PLOS GENETICS (2010)

Article Clinical Neurology

PI3K Signaling in Glioma-Animal Models and Therapeutic Challenges

Christine K. Cheng et al.

BRAIN PATHOLOGY (2009)

Review Biochemistry & Molecular Biology

Blinded by the Light: The Growing Complexity of p53

Karen H. Vousden et al.

Review Biochemical Research Methods

Novel Perspectives of Neural Stem Cell Differentiation: From Neurotransmitters to Therapeutics

Cleber A. Trujillo et al.

CYTOMETRY PART A (2009)

Article Medicine, Research & Experimental

New drugs for brain tumors? Insights from chemical probing of neural stem cells

Phedias Diamandis et al.

MEDICAL HYPOTHESES (2009)

Article Multidisciplinary Sciences

Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease

Mathew Blurton-Jones et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Medical Informatics

Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers

Andrew J. Vickers et al.

BMC MEDICAL INFORMATICS AND DECISION MAKING (2008)

Article Mathematical & Computational Biology

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

RA Irizarry et al.

BIOSTATISTICS (2003)

Article Biochemistry & Molecular Biology

Lysyl oxidase: Properties, specificity, and biological roles inside and outside of the cell

HM Kagan et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2003)

Article Biochemistry & Molecular Biology

Glial cell line-derived neurotrophic factor (GDNF) is a proliferation factor for rat C6 glioma cells: evidence from antisense experiments

B Wiesenhofer et al.

ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT (2000)